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Abstract
The underlying mechanisms involved in the pathogenesis of acute pancreatitis are ill understood. The mortality rate of this
disease has not significantly improved over the past few decades. Current treatment options are limited, and predominantly
aimed at supportive therapy. A key feature of severe acute pancreatitis is the presence of extensive tissue necrosis with both
local and systemic manifestations of inflammatory response syndromes. A better understanding of the underlying
pathophysiology of severe acute pancreatitis may lead to more targeted therapeutic options, potentially leading to improved
survival. Animal models of acute pancreatitis are therefore an essential investigative tool for these aims to be achieved. This
review discusses the suitability of recent non-invasive models of acute pancreatitis such as hormone-induced, alcohol-
induced, immune-mediated, diet-induced, gene knockout and L-arginine; and invasive models including closed duodenal
loop, antegrade pancreatic duct perfusion, biliopancreatic duct injection, combination of secretory hyperstimulation with
minimal intraductal bile acid exposure, vascular-induced, ischaemia/reperfusion and duct ligation.
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Introduction
Acute pancreatitis has a relative frequency ranging
from 5 to 80 cases per 100 000 population in the
Western world. There are several aetiological factors,
the majority being gallstones- or alcohol-related [1,2].
The severity of clinical presentation varies from a
mild, self-limiting form to severe disease complicated
by sepsis and multi-organ failure. About 25% of
patients with acute pancreatitis have severe disease,
with a mortality rate approaching 3040% [3]. The
precise underlying mechanisms of severe acute pan-
creatitis are unknown. The main features of this
condition are pancreatic necrosis and associated
sepsis, with both localized and systemic inflammatory
response syndromes [4,5]. Specific therapy aimed at
the underlying pathophysiological pathways is largely
experimental and so far ineffectual in human studies.
The pathophysiology event of experimental acute
pancreatitis consists of the activation of pancreatic
enzymes within acinar cells, the release of these
activated enzymes in the interstitium, the autodiges-
tion of the pancreas, and the release of activated
pancreatic enzymes and other factors into the circula-
tion that result in the development of multiple organ
dysfunction [69]. Currently, the factors that deter-
mine the ultimate severity of the acute pancreatitis
remain uncertain [1015].
Several concepts of the pathophysiology of acute
experimental pancreatitis have emerged (see refer-
ences/review in Frossard [16]). One concept of the
disease includes maintaining the stability between
anti- and pro-inflammatory cytokines/chemokines
[17,18]. It has been shown that T lymphocytes,
particularly, CD4/ T cells, are important in the
development of tissue injury during acute pancreatitis
in mice [19]. Another concept of the pathophysiology
of acute pancreatitis includes the fine balance between
necrosis and apoptosis. It has been hypothesized that
apoptosis might be a favourable response to acinar cell
injury, suggesting that induction of apoptosis can
effectively reduce the severity of acute pancreatitis
[2022] and may be beneficial in the clinical manage-
ment of acute pancreatitis. An additional concept
includes having a favourable ratio between reactive
oxygen species and free radical scavengers. Animal
models have been shown to exhibit rapid increases in
the concentration of peroxidation products both in
pancreatic tissue and serum, with peak changes
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during the first 6 h after acute pancreatitis induction
[2327]. It has been suggested that reactive oxygen
species play a pivotal role in signal transduction [28],
and may cause alterations in cytoskeleton function
[29]. However, results of well-designed clinical stu-
dies have yet to prove the benefits of enzyme
scavengers to individuals suffering from acute pan-
creatitis [30].
Experimental models of acute pancreatitis resem-
bling the human situation are an integral tool to
increase the understanding of the complex mechan-
isms and in devising therapeutic strategies for this
disease. Several experimental models of severe acute
pancreatitis have been produced. These models may
be arbitrarily divided into invasive and non-invasive
varieties according to the method of induction of
acute pancreatitis.
An ideal model of acute pancreatitis should en-
compass several features. It should be easily reprodu-
cible, with the ability to vary the severity of acute
pancreatitis in a standardized manner according to the
experimental aims. The morphology and pathophy-
siology should resemble that of the human situation.
This article assesses current models of acute pancrea-
titis with particular emphasis on their suitability as a
research tool for the human disease.
Non-invasive models of acute pancreatitis
Several non-invasive models of experimental acute
pancreatitis have been developed in an attempt to
investigate the initiation, progression and treatment of
this disease (Table I).
Hormone-induced model
Caerulein, a cholecystokinin-pancreozymin analogue,
has been used to successfully cause acute pancreatitis
in rats [31,32], mice [33], dogs [34], and Syrian
hamsters [35]. Acute pancreatitis may be induced by
intravenous, subcutaneous or intraperitoneal injection
routes. Using this method, proteolytic enzyme secre-
tion may be increased to levels that cause pancreatic
acinar autolysis [36]. The intravenous route is the
preferred method. It allows accurate control of the
infusion rate, and thus control of the timing and
severity of the acute pancreatitis [31,34,37]. One
hour after infusion of caerulein, progressive interstitial
oedema develops and reaches a maximum after 12 h.
The dose of caerulein may be gradually increased.
Pancreatic enzymes in the blood circulation, pancrea-
tic inflammation, acinar cell necrosis and fat necrosis
can be observed following a two-fold increase in the
caerulein dose [31,3841].
Acute caerulein pancreatitis has been shown to be
particularly effective for investigating the pathogenesis
of pancreatitis-related pulmonary pathology [42,43].
The appearance of the pulmonary injury in rats using
this model resembles the early stages of the adult
respiratory distress syndrome in humans. The struc-
tural changes of acinar cells observed in human acute
pancreatitis exhibit many similar characteristics to
caerulein-induced acute pancreatitis in rats [4446].
In particular, specific changes to intracellular mem-
brane systems of acinar cells were similar in both
human and caerulein-induced acute pancreatitis. This
model appears to simulate the pathophysiology of
acute pancreatitis induced by Trinidadian scorpion
toxin [47] or anti-cholinesterase insecticide [48]
poisoning in humans. Both these agents have been
employed to induce experimental acute pancreatitis in
dogs [49,50].
The advantages of the hormone-induced model are
that it is relatively simple and inexpensive to perform.
This model has been frequently used to study the cell
biology and pathophysiological events in acute pan-
creatitis. It is also useful for studying systemic disease
manifestation. Apart from investigation of the pul-
monary aspects of acute pancreatitis, it has also
proved particularly useful in elucidating information
on gut endocrine interactions such as secretin and
cholecystokinin (CCK) levels. Another advantage of
this model is that it allows investigation of healing and
regeneration of damaged tissue after the toxic sub-
stance has been discontinued.
This model has two major disadvantages. Despite
infusion of maximum doses of caerulein, only mild
acute pancreatitis develops, with negligible mortality.
In addition, the course and severity of the underlying
acute pancreatitis are highly variable and thus rela-
tively unsuitable for controlled studies.
Alcohol-induced model
The acute effects of ethanol on the pancreas have
been investigated in several animal studies in order to
investigate the underlying pathophysiological me-
chanisms leading to alcohol-induced acute pancreati-
tis. Animal models of acute pancreatitis, induced by
acute ethanol application alone, have been difficult to
produce [51,52] and require prior sensitization with
other agents [5356] to allow significant pancreatic
damage to occur. Developing an experimental model
requiring direct ethanol installation via the pancreatic
duct is not relevant in a clinical situation. This is
because installation of any agent corresponding to
concentration and pressure would result in pancreatic
injury. Thus, acute ethanol administration has been
combined with other substances to study the patho-
physiological events. These models have proved
particularly useful to study specific alcohol-induced
effects such as changes to pancreatic blood flow
and the microcirculation, the effect on pancreatic
acinar damage by alcohol-related free oxygen radical
generation, metabolites and the effect on pancreatic
regeneration (see references/review in Schneider et al.
[57]).
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Table I. Summary of the advantages, disadvantages and clinical relevance of non-invasive experimental models of acute pancreatitis.
Model Advantages Disadvantages Clinical relevance References
Hormone-induced . Causes acute pancreatitis in a variety of
animals, i.e. rats, mice, dogs and Syrian hamsters
. Only mild acute pancreatitis develops . Pulmonary injury in rats resembles




. Can induce acute pancreatitis by a number of
injection routes, i.e. intravenous, subcutaneous
or intraperitoneal; the preferred method is
intravenous route
. Negligible mortality . Structural changes of acinar cells are
similar to human acute pancreatitis
. Allows accurate control of the infusion rate,
thereby enabling control of the timing and
severity of acute pancreatitis
. High variability in the course and
severity of underlying acute
pancreatitis and thus unsuitable
for controlled studies
. Specific changes to intracellular
membrane systems of acinar cells
resemble human acute pancreatitis
. Useful for studying cell biology, gut endocrine
interactions such as secretin and CCK levels,
pathogenesis of acute pancreatitis-related
pulmonary pathology, systemic disease
manifestation, and healing and regeneration
of damaged tissue after the toxic substance
has been discontinued
. Simulates acute pancreatitis induced




. Inexpensive to perform
Alcohol-induced . Useful for studying changes to pancreatic
blood flow and the microcirculation, the
effect on pancreatic acinar damage by
alcohol-related free oxygen radical generation,
metabolites and the effect on pancreatic
regeneration
. Animal models of pancreatitis,
induced by acute ethanol application
alone, have been difficult to
produce significant pancreatic
damage, and thus require prior
sensitization with other agents
. Lack of correlation with the
clinical situation
50, 53, 56, 57, 6066
. Has been used in several animal models,
i.e. rats, cats and dogs
. Lack of reproducibility
. Various route of ethanol administration,
i.e. intravenous, oral and direct
intragastric instillation
. Relatively simple
. Cheap to perform
. Selectively lessens pancreatic blood flow
and microcirculation
. Gene knockout animals may be used to
determine the effect of genetic factors on the
development of acute alcohol-related
pancreatic injury
Immune-mediated . Possible application in the field of drug- or
toxin-induced acute pancreatitis













Table I (Continued )




. High early mortality rate, difficult
for studying pathogenesis or
treatment options
. Development of secondary diabetes
due to the involvement of the islets
of Langerhans
Diet-induced . Simplest method to study acute
haemorrhagic pancreatitis
. Species-specific; may only be used
in mice, whose small size causes
technical difficulties
. Produces severe necrotizing that
approximates human pancreatitis
82, 84
. Well-established . Sex-specific; female mice . Gross and histological appearance
of the pancreatic and peripancreatic
inflammation, and clinical and
biochemical course of diet-induced
pancreatitis, resemble the human disease
. Cheap . Variable onset of acute pancreatitis . Ascites, acidosis, hypoxia and
hypovolaemia similar to human acute
pancreatitis
. High reproducibility . Requires careful monitoring to ensure
that intake of the CDE diet is the
same in different experimental groups
. No surgical procedure involved
. Mortality rate can be controlled at any
desired level between 0% and 100% by
modifying feeding protocol
. Useful for studying the pathophysiology
for acute pancreas and potential experimental
treatment by measuring survival, biochemistry,
histology, changes in haematocrit, pH and
blood gases
. Produces haemorrhage and necrosis with a
lethal course
. Inflammatory lesions are homogeneously
distributed
Gene knockout . Useful for studying the function or effect
of a specific gene of interest
. Time-consuming . Extrapolation of experimental
data to humans is difficult
9099, 101107
. Avoids the use of pharmacological


















Table I (Continued )
Model Advantages Disadvantages Clinical relevance References
Altering the specific gene from the
time of its conception could mean that
other protein expressions may result to
compensate for the mutation
. Mutation may stimulate unforeseen
phenotypic changes if a gene is
expressed in different tissues
. Expression of two genes may
overlap and the alteration in
a single gene might
mask an abnormal phenotype
L-arginine (Arg) . High reproducibility . Long-term administration of Arg
produces chronic pancreatitis
induction
. In a clinical situation, the circulatory,
pulmonary, renal and hepatic failure
(multi-organ failure) significantly
affects the morbidity and mortality
of acute pancreatitis
189, 199, 200203
. Ability to achieve selective dose-dependent
pancreatic acinar cell necrosis
. Suitable for investigating the early and late
phases of acute pancreatitis
. Useful for investigating the insulo-acinar axis,













Several animal models have been used including
rats, cats and dogs. The routes of ethanol adminis-
tration include intravenous, oral and direct intragas-
tric instillation. The morphology of the acute
pancreatitis varies according to the animal model,
the dose of ethanol administration and the presensi-
tization agents used. It has recently been established
that ethanol may lead to the onset of acute pancrea-
titis via its effect on intrapancreatic digestive enzyme
activation, by either directly sensitizing acinar cells to
pathologic stimuli [58] or stimulating the release of a
secretagogue, CCK, from duodenal I cells [59].
Although the exact role of the various digestive
enzymes in initiating pancreatitis remains controver-
sial, it has been established that ethanol can directly
interfere with the processes that are involved in
digestive zymogen activation (see references/review
in Lerch et al. [60]).
The model by Siech et al. [51] combines oral
ethanol ingestion and the use of low doses of CCK
and secretin to simultaneously stimulate the glands of
female Sprague-Dawley rats. Histological changes
include evidence of pancreatic duct obstruction,
interlobular oedema, cellular inflammatory infiltrates
and perilobular fat and parenchymal necrosis [51].
Letko et al. [54] used the same model to test the
various modes of ethanol administration and found
that it did not influence the development of acute
pancreatitis. A number of other studies have found
that ethanol can sensitize acinar cells to CCK-induced
procarboxypeptidase A1 processing in vitro and can
sensitize to various forms of acute pancreatitis in vivo
[6164]. In this way, ethanol is thought to increase
stimulation-dependent induction of acute pancreati-
tis, and thus may be important in ethanol toxicity in
the pancreas.
In a study by Wedgwood et al. [65], a cat model of
acute pancreatitis was used to study the direct effects
of oral ethanol (ethanol 20% v/v in milk, 10 ml/kg
every 8 h for 48 h) on the permeability of the
pancreatic duct. After the duct was cannulated and
perfused with activated enzyme solution, the ethanol-
fed cats were induced with acute oedematous acute
pancreatitis and the control cats remained unchanged.
In a separate study, Friedman et al. [66] studied the
effect of ethanol application on pancreatic blood flow
in dogs. They found a reduction in pancreatic blood
flow in the dogs after intravenous infusion of an
ethanol dose that would equate to mild to moderate
alcohol intoxication in human. These pancreatic
blood flow alterations were not detected at compar-
able blood ethanol concentrations in pentobarbital-
anaesthetized dogs [66].
In another new study, Lu et al. [67] found that
trypsinogen and chymotrypsinogen showed distinct
patterns of activation in response to supraphysiologi-
cal concentrations of the CCK analogue caerulein.
They also noted that ethanol and other alcohols
sensitized the acinar cell to caerulein-induced trypsin
and chymotrypsinogen activation, and that other
short-chain n-aliphatic alcohols (methanol, propanol,
and butanol) advanced the effects of caerulein on the
acinar cell. However, when only ethanol was used,
neither acute pancreatitis nor zymogen activation
was induced in experimental models of acute pan-
creatitis. Thus, these studies indicate that CCK
receptor activation can stimulate various patterns of
zymogen activation in pancreatic acinar cells and the
extent of activation can be increased by a distinct set
of short-chain alcohols. It is still not known, however,
whether ethanol and other alcohols mediate these
effects by interfering with acinar cell signalling path-
ways or by affecting acinar cell membrane fluidity.
In 1995, Weber et al. [68] investigated the activity
of oxygen radical generating xanthine oxidase in the
pancreas of rats treated with either dibutyltin dichlor-
ide/ethanol (6 mg/kg/13.7 mg/kg, i.v.), ethanol alone
(13.7 mmol/kg, i.v.), or isotonic saline as control. The
authors measured the activities of oxygen radical
scavengers, superoxide dismutase and glutathione
peroxidase, and determined the levels of the lipid
peroxidation marker, malondialdehyde. Weber et al.
[68] found that tissue imbalance between oxidants
and antioxidants may be important in the pathogen-
esis of dibutyltin dichloride/ethanol-induced acute
interstitial pancreatitis, and that although ethanol
increases oxygen radical generation, more damage is
needed for acute pancreatitis to develop.
Werner et al. [69] studied the acute effects of
ethanol on the pancreas by the infusion of non-
oxidative products of ethanol metabolism such as
fatty acid ethyl esters in Sprague-Dawley rats. They
observed increases in pancreatic oedema formation,
pancreatic trypsinogen activation and vacuolization of
acinar cells. The authors also concluded that fatty
acid ethyl esters at concentrations found in human
plasma produce an acute pancreatitis-like injury in
rats, providing direct evidence that fatty acid ethyl
esters can produce organ-specific toxicity. Fatty acid
ethyl esters may be important in acute alcohol-
induced damage to the pancreas.
Existing alcohol-induced models are relatively sim-
ple and cheap to perform. Acute ethanol administra-
tion selectively lessened pancreatic blood flow and
microcirculation, suggesting that the effect of alcohol
might increase ischaemia damage during the evolve-
ment of acute pancreatitis with or without underlying
chronic disease. Another advantage of this model is
that it allows alcohol to directly damage the pancreas
by the influence of toxic ethanol metabolites, and
perhaps by limitations of pancreatic regeneration.
Reproducibility, however, has not been successfully
achieved. Furthermore, there is a lack of correlation
with the clinical setting. Gene knockout animals
may be used to determine the influence of genetic
factors on the development of acute alcohol-related
pancreatic injury.
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Gene knockout model
Gene knockout models have been developed to
further understand how specific genes might regulate
acute pancreatitis. The method requires precise re-
moval of the specific gene of interest and replacing it
with a mutant gene that is inactive, altered or
irrelevant. Rinderknecht [18] first commented that
the severity of the local disease and the systemic
complications may increase due to the inappropriate
activation of the immune system. In recent years,
there has been accumulating evidence demonstrating
that synthesis and release of proinflammatory cyto-
kines and chemokines influence the local injury and
the systemic dispersion of the inflammation. Gene
knockout models may be used to examine the effects
of cytokine and chemokine mediators as well as their
receptors in the pancreas and distant organs. It has
been shown that the deletion or alteration of a single
gene does not entirely prevent injury in the pancreas
or remote organ. This is indicative of many redun-
dancies of ligands and receptors characteristic of the
cytokine and chemokine families. Gene knockout
models have been used to determine the function of
several specific targeted genes such as interleukin
(IL)-1 and tumour necrosis factor-a [7073], IL-6
[74], IL-10 [75], chemoattractant cytokine receptor-1
[76], neurokinin-1 receptor [77,78], intercellular
adhesion molecule-1 (ICAM-1) [7981], metal-
lothionein-1 [82], cathepsin B [83], mouse a2-macro-
globulin and murinoglobulin [84], complement factor
C5a [85,86], granulocyte-macrophage colony-stimu-
lating factor [20] and phospholipase A2 [87].
Knockout models are increasingly used to examine
the cause and course of acute pancreatitis. The
advantage of the gene knockout models is that by
deleting the specific gene of interest, its function or
effect can be revealed or clarified. Furthermore, the
use of pharmacological manipulations which often
cause side effects can be avoided. This allows in-
vestigation of the effects of a specific cytokine to be
carried out. In general, the gene knockout model is
time-consuming, expensive and complex to perform.
Another disadvantage is that the specific gene altera-
tion from the time of its conception could mean that
other protein expressions may result to compensate
for the mutation. In addition, the mutation may
stimulate unforeseen phenotypic changes if a gene is
expressed in different tissues. On the other hand, the
expression of two genes may overlap and the alteration
in a single gene might mask an abnormal phenotype.
Any extrapolation of experimental data from gene
knockout models to humans is therefore difficult.
Immune-mediated model
Immune-mediated models of acute pancreatitis may
be induced by both non-invasive and invasive means,
usually involving pancreatic intraductal infusion of a
variety of agents. Thal and Brackney [88] first
described an immunologically induced acute pancrea-
titis model by infusing bacterial toxin of Escherichia
coli and meningococci into the pancreatic duct of
goats and rabbits. This produced a local Shwartzman
reaction in the pancreas. The authors administered
the same toxin 24 h later which led to acute haemor-
rhagic and necrotizing pancreatitis. None of the
animals survived within 424 h after the second
doses [88]. In a separate study, Thal [89] reported
other varieties of acute pancreatitis associated with an
Arthus phenomenon which involved sensitizing rab-
bits by intravenous or subcutaneous administration of
ovalbumin. The degree of pancreatitis ranged from
acute non-fatal interstitial pancreatitis to severe pan-
creatic necrosis. Thal [89] observed that both types of
experimental acute pancreatitis resembled the inter-
stitial and necrotic forms seen in humans. The
morphological studies of these models have suggested
that vascular factors induced by both the Shwartzman
and Arthus reactions have been identified as playing a
major role in the pathophysiologic pathways of this
model of experimental acute pancreatitis.
Acute pancreatitis has also been induced by an
intraperitoneal injection of foreign serum in mice.
This model is characterized by acinar cell necrosis, fat
necrosis, hyperamylasaemia and inflammatory re-
sponse syndromes [90,91]. Nevalainen [92] described
another model of acute necrotizing pancreatitis by
injecting fresh rabbit serum either intraperitoneally or
into the rat pancreatic duct. Features of early mem-
brane impairment resulting in osmotic damage, death
and necrosis of affected acinar cells were observed
[92]. Other immunology-based models have been
documented [93,94]. These include intraductal ad-
ministration of anti-acinar cell antiserum to rats
causing a progressive inflammatory process leading
to severe necrosis within 16 h of induction. A
spontaneous model of autoimmune acute pancreatitis
in the MRL/MP strain of mice has also been
described [95]. Histological features include severe
inflammatory changes and extensive acinar tissue
necrosis, which appear to be mediated by cellular
autoimmune mechanisms, in particular, CD4/ cells
[95]. Acute pancreatitis in this model may be induced
in genetically different animals by the transfer of
spleen cells from the affected animal [95].
Immune-mediated models are not recommended
for the study of acute pancreatitis. These models are
challenging to set up in the laboratory, time-consum-
ing, have limited reproducibility, are costly, and the
clinical relevance is unclear [96]. The high early
mortality rate makes investigation of pathogenesis or
treatment options difficult to assess. Another major
disadvantage of this model is the development of
secondary diabetes due to the involvement of the islets
of Langerhans [97]. One possible application of this
model is in the field of drug- or toxin-induced acute
pancreatitis [97].
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Diet-induced model
Lombardi et al. [98] developed a diet-induced
model of acute pancreatitis by inducing severe acute
necrotizing pancreatitis in young female mice fed a
choline-deficient diet containing ethionine (CDE
diet). The synergistic effect of choline deficiency and
ethionine administration may be manipulated to
achieve the desired mortality rates. Animals fed with
choline-sufficient diets and ethionine 0.5% leads to a
mortality rate approaching 10%. A choline-deficient
diet without ethionine did not cause any mortality nor
acute pancreatitis [99]. By modifying the feeding
protocol established by Lombardi et al. [98], Gilliland
and Steer [100] were able to decrease the severity of
diet-induced acute pancreatitis. The CDE diet was
reduced in terms of amount (3 g per mouse) and
duration (24 h). The exposure to CDE diet feeding
was performed before and after 24 h of fasting. From
this modification, a mortality rate between 50% and
60% resulted. Glucagon has been shown to reduce the
mortality rate and severity of acute pancreatitis if
administered prior to a CDE diet. Pancreatic poly-
peptide also decreased mortality rate and severity of
acute pancreatitis. This model therefore allows grada-
tion of the severity of acute pancreatitis and mortality
for therapeutic trials or cell biological studies.
The advantage of the diet-induced model is that it is
perhaps the simplest system to establish for the
investigation of acute haemorrhagic pancreatitis. It is
also cheap, highly reproducible and no surgical
procedure is involved. Furthermore, by restricting
the period of feeding, the mortality rate can be
controlled at any desired level between 0% and
100% [101]. The model is suitable for studying the
pathophysiological aspects of the disease and the
potential benefit of experimental treatment by mea-
suring survival, biochemistry, histology, alterations in
haematocrit, pH and blood gases [102]. In compar-
ison to the mild and oedematous varieties of acute
pancreatitis produced by the caerulein model, this
diet-induced model produces a haemorrhagic and
necrotizing appearance of the disease with a lethal
course. The inflammatory lesions in these models are
homogeneously distributed. The model is substan-
tially defined and reliably produces severe necrosis
that approximates human acute pancreatitis. It has
been demonstrated that both the gross and histologi-
cal appearance of the pancreatic and peripancreatic
inflammation, in addition to the clinical and biochem-
ical course of diet-induced acute pancreatitis, reflect
the human disease. The presence of ascites, acidosis,
hypoxia and hypovolaemia can be found in this diet-
induced model as well as in human acute pancreatitis.
Although the morphological alterations have many
similar features between mouse and man [103], the
relevance to the aetiology of human acute pancreatitis
is doubtful. The model produces 80100% mortality
after 28 days. The mortality, however, may be
related to causes other than acute pancreatitis. In-
dependent of acute pancreatitis, animals also have
changes in the liver and central nervous system which
contribute to multiple organ failure.
Furthermore, the diet-induced model is species-
specific and may be used only in mice, whose small
size causes considerable technical limitations. The
model is also sex-specific. In contrast, male mice are
resistant to the induction of acute haemorrhagic
pancreatitis by a choline-deficient diet containing
DL-ethionine [104]. Male mice with a body weight
over 20 g usually show a less severe acute pancreatitis
with a much lower mortality rate [49]. The adminis-
tration of oestrogen increases the susceptibility of
male mice to acute pancreatitis [105]. The onset of
the acute pancreatitis is variable and careful monitor-
ing is required to ensure that the intake of the CDE
diet is the same in different experimental groups
[99,101].
L-Arginine model
Another non-invasive rat model of acute pancreatitis
was developed by Mizunuma et al. [106]. This model
produces acute necrotizing pancreatitis by adminis-
tration of a large dose of L-arginine (Arg). The
mortality is 2.5% [107]. The mechanism by
which Arg causes acute pancreatitis is currently
unknown. It has been proposed that oxygen free
radicals [108112], nitric oxide [113], and inflam-
matory mediators [111,114116] may be involved in
the development of this disease. Hegyi et al. [107]
noted that the weight of the pancreas almost doubled
within 24 h. Under electron microscopy, Kishino
et al. [117] noticed that degeneration began with the
disarrangement of the rough endoplasmic reticulum
in pancreatic acinar cells. Initial distension of the
endoplasmic reticulum was followed by disarranged
rough endoplasmic reticulum and degraded zymogen
granules. This was followed by necrosis of acinar cells
with leukocyte and fibroblast infiltration.
The single Arg injection model has been modified
with varying results. Higher doses of/500 mg/100 g
bm can induce death within a few hours [118].
Repeated dosing can increase the proportion of acinar
cell necrosis. A single dose of 500 mg/100 g bm causes
necrosis in up to 7080% of the pancreatic acinar
cells within 3 days, which increases to 90% with three
further doses over 10 days [118]. Reduced doses over
a longer time period can also be used to delay the time
of onset of acute pancreatitis [119].
In 2004, Hegyi et al. (107) characterized the early
and late phases of the Arg-induced model in the rat.
The early phase of acute pancreatitis is characterized
by acute pancreatic inflammation with intercellular
oedema infiltration of leukocytes, capillary dilatation
and microfocal parenchyma necrosis. The acinar cells
surrounding the Langerhans inlets remained intact.
Prominent adipose tissue deposition was seen at the
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end of the first week. This adipose tissue accruement
is an indication of atrophy in affected areas and may
represent hypertrophy and hyperplasia in unaffected
areas. The deaths of the rats occurred between days 1
and 5 following acute pancreatitis induction, with no
mortality in control groups.
The benefits of the Arg-induced model include its
high reproducibility and its ability to achieve selective
dose-dependent pancreatic acinar cell necrosis. Due
to the dose and time dependency of the effects of Arg,
this model is very good for investigating the early and
late phases of acute pancreatitis. A smaller dose of Arg
is useful for characterizing the regenerative processes
of acute pancreatitis. Long-term administration of
Arg, however, results in chronic pancreatitis
[119,120]. This model is also useful for investigating
the insulo-acinar axis. In a clinical situation, the
circulatory, pulmonary, renal and hepatic failure
(multi-organ failure) significantly affects the morbid-
ity and mortality of acute pancreatitis [121123].
Thus, this model may be suitable for researching
extra-pancreatic organ damage and its mechanisms.
Invasive experimental models
The highly variable severity of acute pancreatitis
associated with the non-invasive models as well as
the ill-defined temporal relationship of onset has led
to the development of invasive models to overcome
these problems (Table II). In addition, the aetiology of
the non-invasive models has minimal relevance to the
clinical situation. Most invasive animal models of
acute pancreatitis simulate mechanisms relevant to
gallstone-induced acute pancreatitis observed in clin-
ical situations.
Closed duodenal loop model
Experimental acute pancreatitis in animals may be
produced by creating a closed duodenal loop (CDL).
This technique involves surgically closing above and
below the duodenal papilla while bile is diverted into
the jejunum via an implanted cannula. The model was
first developed by Pfeffer et al. [124] in an attempt to
improve the extensive variability experienced when
using the retrograde duct-injection models. Evidence
of oedema, haemorrhage and necrosis of the pancreas
developed within 911 h. No inflammation or fat
necrosis was evident. Pfeffer et al. [124] concluded
that the vascular factors influenced the formation of
tissue necrosis. The CDL model is more representa-
tive as a model of pancreatic necrosis than as a model
of pancreatic inflammatory disease.
This model has since undergone a number of
modifications and has been employed in various
animal species. In a study by Byrne and Joison
[125], it was shown that acute haemorrhagic pan-
creatitis may be prevented by inserting antibiotics in
the duodenum after a CDL had been performed. This
suggests that the bacteria may contribute to the
pathogenesis of acute haemorrhagic pancreatitis
[125]. The study by Nance et al. [126] however,
demonstrated that the surgical creation of a CDL in
germ-free dogs still induced acute pancreatitis.
Furthermore, primates develop acute pancreatitis
only if the CDL is combined with stimulation of the
pancreas [127]. Hence, differences between different
animal species must be taken into account when
considering this model. It is now clear that the
mechanism of acute pancreatis is triggered by the
reflux of duodenal contents into the pancreatic duct,
and the pathogenesis in the CDL animal model is
based on this principle.
Nevalainen and Seppa [128] also conducted a
modification of CDL in rats. An intraduodenal tube
was placed prior to ligating the duodenal loop in order
to restore the continuity of the gastrointestinal tract.
Within 24 h, acute haemorrhagic pancreatitis was
visible in the animals. The findings support the view
that reflux of the duodenal contents into the pancrea-
tic duct is an important early pathogenetic mechanism
in the development of acute pancreatitis. Chetty et al.
[129] performed another modification of the techni-
que by instilling infected bile into the closed loop
under pressure, at a known time, in the rat. This
resulted in the production of a lethal haemorrhage,
periductal abscess formation and fat necrosis. The
model of Chetty et al. [129] produces a consistently
severe acute pancreatitis in comparison with the
model produced by Nevalainen and Seppa [128].
Since the permanent ligation of the duodenum
often caused death of the animal within a short
period, some investigators have attempted temporary
ligation of the duodenum in rats [130,131]. This
allowed them to examine the progression of acute
pancreatitis at an extended time and to investigate
potential therapies. In a study by Orda et al. [131], the
authors injected a mixture of sodium taurocholate and
trypsin into a temporary CDL to induce acute
pancreatitis in rats. They found that the acute
pancreatitis induced was mild, associated with a
mortality rate of 45%. Recent studies have demon-
strated a number of treatments that have an effect on
both the course and severity of acute pancreatitis.
These include protease inhibitors [131,132], trypsin
inhibitors [134136], somatostatin [137], prostaglan-
din E1 [138], vasopressin [139] and dextran 40 [140].
The CDL model has helped address some of the
issues regarding the aetiology of acute pancreatitis,
specifically the role of duodenal reflux in the patho-
genesis of the disease in humans. The model is
advantageous because of its simplicity and reproduci-
bility. It is suitable for experiments on small animals
such as rats and thus is relatively economical. Dis-
advantages of this model include the need for surgical
intervention, the non-physiologic pressure levels cre-
ated in the closed duodenal compartment and the
pancreatic duct, and the controversial role of bacterial
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Table II. Summary of the advantages, disadvantages and clinical relevance of invasive experimental models of acute pancreatitis.
Model Advantages Disadvantages Clinical relevance References
Closed duodenal
loop (CDL)
. Relatively simple . Requires surgical intervention, the
non-physiologic pressure levels
created in the closed duodenal
compartment and the pancreatic
duct, and the controversial role
of bacterial infection
. Closely resembles the few patients
who develop acute pancreatitis in
association with afferent loop
obstruction after Billroth II
gastrectomy
108110, 112115
. Reproducible . Not widely used
. Useful for studying the role of duodenal reflux
in the pathogenesis of acute pancreatitis in
humans
. Suitable for experiments on small animals
(i.e. rats) and thus economical
Antegrade pancreatic
duct perfusion
. Useful for studying early pathophysiology
and subsequent progression of acute pancreatitis
. Complex (ductal cannulation
and perfusion)
. Aetiology and morphological
changes closely resemble the
human situation
126129
. Reliable . Often requires large animals
(i.e. cats) which are expensive and
difficult to maintain
. Reproducible
. Pancreatitis severity may be varied within
well-defined time intervals according to the
volumes and perfusion pressures
. Ideal for assessing potential therapeutic
agents (i.e. cholecystokinin antagonists,
somatostatin, fibrinolytic agents and
cytokine antagonists)
. Perfusion of an isolated segment of the
rat pancreatic duct with bile salt increases
its permeability; therefore smaller and cheaper
animals can be used (i.e. rats)
Biliopancreatic
duct injection
. Suitable for studying systemic issues of
acute pancreatitis
. Technically challenging to control
constant pressure recordings and
hence produce a standard degree
of injury
. Clinical and pathogenetic
relevance unclear
131, 136138
. Useful for studying pseudocyst formation,
pancreatic abscess and fatty tissue necrosis
. Difficult to establish the degree of
variation regarding tissue necrosis
and survival in animal groups
. Limited evidence to support the
role of bile reflux in the human
condition where the bile
concentration in the general tissue
is higher than the pancreatic
tissue concentration
. Reproducible model for creating a severe,
rapidly evolving, and lethal variety of acute
haemorrhagic pancreatitis
. Surgery is restricted to simulate the
type of obstruction that would take
place during the passage of gallstones
















Table II (Continued )
Model Advantages Disadvantages Clinical relevance References
Combination of secretory
hyperstimulation with
minimal intraductal bile acid
exposure
. Combined action of low-dose intraductal
GDOC with intravenous caerulein causes
acute pancreatitis more reliably than
induction by either component alone
. High concentrations of bile acids
produce extensive acinar necrosis
too rapidly and the resulting lesions
show substantial heterogeneity
Homogeneous injury has a
moderately severe acute pancreatitis
that impairs all regions of the gland, resembling
human acute pancreatitis
139
. Accelerated detergent effect is not elicited
when using very low dose of GDOC
(5 or 10 mmol/l); the bile salt is dispersed
throughout the periphery of the pancreas
. Applying very low concentrations
of GDOC (5 or 10 mmol/l)
produces non-remarkable acute
pancreatitis, with no death
. Relatively easy to perform
. Reproducible
. Relatively inexpensive
. Mortality rates vary between 6% and 42% at 24 h
. Pancreatic cell injury is progressive over
at least 24 h
. Produces homogeneous injury of
intermediate rate of onset suitable for
scoring and testing treatments
. Pancreatic injury can be manipulated by
controlling the amount and time of
infusion of intraductal low-dose GDOC
Vascular-induced Microcirculatory disturbance Microcirculatory disturbance . In a clinical setting, acute pancreatitis
caused by occlusion of a main artery
is not a common event; it is
sometimes observed in patients
with arteritis
149, 150, 152156
. Acute haemorrhagic necrotizing pancreatitis
can be reproduced by using microspheres
of diametersB/20 mm
. Maintaining the normality of other
organs during the cannulation of
pancreatic vessels is difficult
. Microcirculatory disturbance models
increase capillary permeability,
similar to clinical situation
. Induction of hypovolaemic shock significantly
lowers pancreatic blood flow, thus may
potentially be used to study pancreatic
damage in cardiac surgery
. Useful for studying coagulopathy and
thrombosis of microvessels caused by
acute pancreatitis
. Allows the study of endothelin receptor
antagonists (i.e. ET-RA, PAF-RA,
ICAM-1-AB); ET-RA is most effective
Pancreatic artery occlusion
. May potentially be used to study pancreatic
damage in cardiac surgery
. Allows relative preservation of islet cell function
Pancreatic venous occlusion
. May be used to study acute splenic vein or













Table II (Continued )
Model Advantages Disadvantages Clinical relevance References
Overall





. Not suitable for investigating
local changes in the pancreas
. Not easily reproducible
Overall
. Vascular-induced models do not
reliably induce equivalent severity
of acute pancreatitis
. Reproducibility sometimes limited
due to extensive collateral network
of pancreatic circulation
. Require large experimental animals
. Surgical procedures are time-consuming
. Minimal histological changes of
acute pancreatitis
. May eventually progress to chronic
pancreatitis
Ischaemia/reperfusion . Hoffman’s model allows complete and
reversible interruption of arterial blood
supply to the pancreas
. Current models  incomplete
ischaemia and inability to quantitate
the remaining blood supply to the
pancreas; irreversible ischaemia,
making it unsuitable for reperfusion
studies; and complete and reversible
ischemia, limited to ex vivo models
. Ultrastructural changes after 2 h
of ischaemia simulate acinar




. Intravital fluorescence microscopy enables
the parameters of microcirculation during
the entire reperfusion period to be
assessed repetitively and quantitatively
. Quantitative analysis of post-ischaemic
reperfusion failure at the
microcirculation level is difficult
to achieve
. Various methods, i.e. methylene blue
or India ink injection, radioactive
microspheres injection, light and
electron microscopic analysis of
microangiographic architecture or
laser Doppler flowmetry cannot be used
Duct ligation . Avoids artificial drug usage that may
produce unwanted systemic effects and
the theory relating to clinical acute biliary
acute pancreatitis with biliary pancreatic reflux
. Cannot induce acute pancreatitis
by surgical ligation of pancreatic
duct alone
. Ligation of the common
biliopancreatic duct in the rat
causes a clinical syndrome
resembling the multiple organ
failure seen in humans

















Table II (Continued )
Model Advantages Disadvantages Clinical relevance References
. Most laboratory animals develop
chronic lesions in the pancreas
characterized by atrophy and
apoptosis of acinar and ductal tissue,
but not significant necrosis or
inflammation
. Main clinical correlation of duct
ligation-induced pancreatitis is the
acute pancreatitis seen after
Polya gastrectomy
. Technically difficult to perform
. Expensive
. Limited reproducibility
. Analogous to chronic pancreatitis
Duct-ligated
Opossum/possum
Opossum Opossum Opossum 179182, 184, 186
. Ligation of the pancreatic duct alone, bile
and pancreatic duct separately, or the
common biliopancreatic duct leads to
severe acute pancreatitis
. Closely simulates the mechanical
events that occur during or after
gallstone passage
. Mortality rates approach 100% within
2 weeks of induction
. Useful for investigating pathophysiology
of biliary acute pancreatitis
. Necrosis is the primary mechanism; apoptosis
is only present in the early stages of
acute pancreatitis
Possum Possum Possum
. Well characterized . Co-existing duodenal wall necrosis,
and pancreatic peritoneal sepsis often
add complexity to the model; this
complicates interpretation of results
. The arrangement of the pancreatic
and bile ducts come together and
are controlled by an SO complex,
resembling those of humans
. Useful for studying the motility of the
sphincter of Oddi (SO); it functions as a
variable resistor in modulating bile and
pancreatic secretion
. Suitable for investigating the role of SO
motility in other forms of acute pancreatitis,
i.e. gallstone pancreatitis, and pancreatitis
secondary to alcohol, scorpion envenomation,
organophosphate poisoning, and octreotide
treatment
. Responses to hormonal and
drug stimuli are similar to humans














infection. The CDL model is thought to closely
resemble the few patients who develop acute pancrea-
titis in association with afferent loop obstruction after
Billroth II gastrectomy. On the whole, the CDL
technique has not been widely used due to the
associated limitations and the availability of other
models [141].
Antegrade pancreatic duct perfusion model
The antegrade duct perfusion model has played a
significant role in the understanding of the underlying
mechanisms in the initial induction of acute pancrea-
titis. The main pancreatic duct can be made perme-
able by the perfusion of glycodeoxycholic acid
(GDOC) along the main pancreatic duct. Other
methods include the administration of intragastric
ethanol, the stimulation of pancreatic secretion into
an obstructed duct, or causing acute hypercalcaemia.
Thereafter, activated pancreatic enzymes are perfused
via the main pancreatic duct using a cannula im-
planted into the duct in the tail of the pancreas. The
perfusion pressure is maintained at 20 cm H2O, which
is less than the maximal secretory pressure in the
pancreas of the cat [142144]. Acute oedematous
pancreatitis develops if activated pancreatic enzymes
are perfused following early induced changes in ductal
permeability [142]. The initial mild acute oedematous
pancreatitis may be converted into an acute necrotiz-
ing pancreatitis by simultaneous infusion of the stable
prostaglandin analogue 16-16-dimethyl-prostanglan-
din E2 [143]. This low-pressure duct perfusion model
causes acute pancreatitis in cats resembling human
changes and may be ideal for the study of severe
necrotizing disease [142144]. Olazabal et al. [145]
reported that perfusion of an isolated segment of the
rat pancreatic duct with bile salt increased its perme-
ability. Thus, this technique can be used on smaller
animals, making it more economical.
The advantages of the pancreatic duct perfusion
model are its reliability and reproducibility. The
severity of the acute pancreatitis may be varied within
well defined time intervals according to the volumes
and perfusion pressures. The aetiology and the
morphological changes closely resemble the human
situation. This model is suitable for studying the early
pathophysiology and subsequent progression of the
disease. It is the ideal model to assess potential
therapeutic agents, including CCK antagonists, so-
matostatin, fibrinolytic agents and cytokine antago-
nists (see references/review in Bilchik et al. [146]).
Furthermore, this model allows the ability to modify
duct obstruction to study chronic pancreatitis.
The major disadvantage of this model is its
complexity (ductal cannulation and perfusion). Other
disadvantages include the need to use large
animals such as cats which are expensive and difficult
to maintain. However, once standardization is
achieved, it remains one of the most suitable models
to assess the underlying pathophysiology of severe
acute pancreatitis and the effects of any therapeutic
intervention.
Biliopancreatic duct injection model
Various compounds have been infused into the
pancreatic duct to induce acute pancreatitis [147
151]. Following a duodenotomy, a retrograde injec-
tion of bile salts (with or without activated pancreatic
enzymes) into the pancreatic duct at the ampulla leads
to severe acute pancreatitis. The severity of the disease
can be manipulated by changing either the pressure or
the concentration of bile salt used. Acute severe
pancreatitis develops within 224 h and is character-
ized by oedema, necrosis and haemorrhage. Almost
any form of detergent injected into the pancreatic
duct under pressure will cause acute pancreatitis in
laboratory animals such as dogs [152] and rats
[147,153,154]. One of the best standardized com-
pounds to use to develop acute pancreatitis is sodium
taurocholate. Infusion of 0.2 ml/kg of 3%, 4.5% or
5% solution induced acute haemorrhagic pancreatitis
with 72-h mortality rates of 24%, 71% and 100%,
respectively [147,153,154]. This model is appropriate
for studies of systemic issues.
The retrograde injection of bile salts into the
pancreatic duct of animals is an easy, effective and
reproducible model for creating a severe, rapidly
evolving and lethal variety of acute haemorrhagic
pancreatitis. This model may also be used to study
pseudocyst formation, pancreatic abscess and fatty
tissue necrosis. Haemorrhagic and necrotizing forms
of acute pancreatitis have been reproducible for
therapeutic studies when specific, low concentrations
of bile salts [155,156] were used.
An important limitation of the biliopancreatic duct
injection model is its clinical and pathogenetic rele-
vance. There is limited evidence to support the role of
bile reflux in the human condition where the bile
concentration in the general tissue is higher than the
pancreatic tissue concentration [157]. It is also
technically challenging to control constant pressure
recordings and hence produce a standard degree of
injury. Another disadvantage of this technique is the
injection pressure with which the solution is applied to
cause severe acute pancreatitis [158]. Solutions such
as normal saline can produce acute pancreatitis when
injected to high pressures [159]. Current studies have
tried to overcome this artefact [160] by applying very
low perfusion pressures and defined injection intervals
to yield reproducible results [155]. In addition, it is
critical to establish the degree of variation regarding
tissue necrosis and survival in the animal groups.
Another limitation is that surgery is restricted to
simulate the type of obstruction that would take place
during the passage of gallstones via the papilla of
Vater.
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Combination of secretory hyperstimulation with minimal
intraductal bile acid exposure model
A new model has been characterized by Schmidt et al.
[155] to improve the limitations of acute pancreatitis
models described above. This model involves a
combined action of low-dose intraductal glycodeoxy-
cholic acid (GDOC) with intravenous caerulein. The
combination of both agents causes acute pancreatitis
more reliably than induction by either component
alone. This model produces a homogeneous injury
with a moderately severe acute pancreatitis that
impairs all regions of the gland, similar to human
acute pancreatitis.
The disadvantage of this model is that a high
concentration of GDOC (34 mmol/l) does not
produce desirable results. It causes substantial acinar
necrosis to form too quickly and the resulting lesions
show considerable heterogeneity. On the other hand,
using a very low dose of GDOC (5 or 10 mmol/l) is
more advantageous because the accelerated detergent
effect is not elicited. Furthermore, the bile salt is
dispersed throughout the periphery of the pancreas.
However, the limitation of applying very low concen-
trations of GDOC is that the acute pancreatitis
produced is not remarkable, with no death.
This new model is advantageous because it is easy
to perform, reproducible and inexpensive. The mor-
tality rates vary between 6% and 42% at 24 h. In
addition, the pancreatic cell injury produced is
progressive over at least 24 h. The model produces
homogeneous injury of intermediate rate of onset,
which can be reliably scored for comparisons and
enable treatment to be easily modulated. Pancreatic
injury may be manipulated to become more severe
and death is advanced by further increasing the
amount and time of infusion of intraductal low-dose
GDOC.
Vascular-induced model
Clinical syndromes associated with microvessel ab-
normalities are a rare cause of acute pancreatitis in
humans. Acute pancreatitis may occur infrequently in
polyarteritis nodosa, and in various coagulopathic
states associated with microvascular thrombosis
[161]. Ischaemia from occlusion of the major arterial
or venous supply of the pancreas may also be a rare
cause of acute pancreatitis in humans. Various models
have been developed to examine the vascular mechan-
ism that produces acute pancreatitis.
Microcirculatory disorder is the major cause of
death in the course of severe acute pancreatitis [162].
Experimental evidence has shown that microcircula-
tory disturbances in this disease not only initiate tissue
damage locally, but also in distant organs including
the colon, liver, lungs and kidney [163]. Hence,
microcirculatory disorders are thought to be crucial
in the development of acute pancreatitis-associated
multiple organ dysfunction syndrome [164].
In 1962, Pfeffer et al. [165] found that intravascular
injection with 1020 mm microsphere diameter
caused minimal oedema; 2040 mm induced moder-
ate oedema, parenchymal necrosis and inflammation;
and 1020 mm induced acute haemorrhagic necrotiz-
ing pancreatitis. There was also a significant increase
in serum amylase levels. The results of this study were
reproducible. A disadvantage of inducing acute pan-
creatitis by disturbing the pancreatic microcirculation
is the difficulty in maintaining the normality of
other organs during the cannulation of pancreatic
vessels. The advantage of this method is that acute
haemorrhagic necrotizing pancreatitis can be repro-
duced by using microspheres of diameters below
20 mm. This is particularly useful in the study of
coagulopathy and thrombosis of microvessels caused
by acute pancreatitis.
Other models have been developed to simulate the
impairment of pancreatic inflow and outflow or the
disturbances of the pancreatic microcirculation. In
1974, Lefer and Spath [166] induced hypovolaemic
shock in dogs by bleeding them to a mean arterial
pressure of 45 mmHg for 3 h. Electron microscopy
showed that the lysosomes and zymogen granules
became enlarged, and cathepsin D increased by
27-fold. Barzilai et al. [167] also used dogs to induce
hypovolaemic shock. The dogs were bled for a period
of 3 h to a higher mean arterial pressure of 60 mmHg.
The authors found oedema and acinar cell necrosis in
the pancreas. They also found that hypovolaemic
shock significantly lowered pancreatic blood flow.
The model may potentially be used to study pancrea-
tic damage in cardiac surgery [168]. This model is
now specific and produces multiple systemic hypo-
tensive changes.
There is experimental evidence that microcircula-
tory disturbances involve not only decreased capillary
blood flow but also enhanced leukocyteendothelial
interaction and increased capillary permeability
[169]. High capillary permeability, in particular,
represents a relevant clinical problem. Several studies
have attempted blocking vasoactive mediators such as
endothelin (ET-1), platelet-activating factor (PAF)
and intercellular adhesion molecule-1 (ICAM-1), in
the same model of severe acute pancreatitis to study
their effects. Eibl et al. [169] noted that endothelin
receptor antagonist (ET-RA), PAF receptor anta-
gonist (PAF-RA) and intercellular adhesion mole-
cule-1 antibody (ICAM-1-AB) improved microcircu-
lation in acute pancreatitis, confirming previous
studies. Moreover, the authors found that ET-RA is
the most effective in reducing microcirculatory dis-
orders, particularly in decreasing capillary leakage.
Therefore, endothelial receptor blockade could be
useful for a clinical trial to attenuate capillary leakage
in individuals with acute pancreatitis.
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In addition, various studies have been performed to
occlude pancreatic arteries. In 1986, Spormann et al.
[170] occluded the coeliac axis and the superior
mesenteric artery for 20 min and found a three-fold
increase in serum amylase after 4 h. They did not find
any histological changes in the pancreas. In another
study, Pfeffer et al. (165) performed a permanent
ligation of the superior pancreaticoduodenal artery
and observed a rise in pancreatic enzymes and
parenchymal necrosis in the head region of the
pancreas. The main disadvantage of this model is its
limited reproducibility. Redha et al. [171] also re-
ported an induction of acute haemorrhagic pancrea-
titis by partially occluding the arterial supply to the
pancreas of the rat. This technique required a
laparotomy and delivering the spleen into the wound.
A microcannula was used to isolate a distal branch of
the splenic artery. Polystyrene microspheres were
introduced into the artery. The cannula was then
removed and the vessel ligated. Alterations of the
pancreas can be identified within 30 min of induction
by immunohistochemical techniques [171]. Within
24 h, there was extensive pancreatic oedema, inflam-
matory cell infiltrate, haemorrhage and fat necrosis
[171]. An advantage of the pancreatic artery occlusion
model is relative preservation of islet cell function
[97]. On the whole, pancreatic artery occlusion
models are not useful for investigating acute pancrea-
titis. In a clinical setting, acute pancreatitis caused by
occlusion of a main artery is not a common event. It is
sometimes observed in patients with arteritis.
A number of studies have also been performed to
study the occlusion of pancreatic veins. Pfeffer et al.
[165] investigated the permanent occlusion of the
pancreatic outflow in dogs. They injected micro-
spheres of 2040 mm diameter via the superior
pancreaticoduodenal vein into the pancreas. The
pancreas and serum amylase remained normal. There
was also no evidence of morphological changes in the
pancreas. In contrast, Sjovall et al. [172] found a four-
fold increase in amylase concentration in rats after
ligating the splenic and superior pancreaticoduodenal
vein. They also observed oedema and interstitial
haemorrhage in the pancreas 25 h after ligation.
Shibayama et al. [173] found mild oedema and
haemorrhage in the pancreas within 24 h of partial
or complete venous obstruction in rats. The major
disadvantage of occluding pancreatic veins is its
unsuitability for investigating local changes in the
pancreas. Furthermore, partial vein occlusion is not
easily reproducible. The pancreatic venous occlusion
model may be used to study the pathophysiology of
acute pancreatitis in acute splenic vein or portal vein
thrombosis.
The advantage of the vascular model is that it is
relatively inexpensive. The model does not reliably
induce equivalent severity of acute pancreatitis. The
reproducibility of this model is sometimes limited
because of the extensive collateral network of the
pancreatic circulation. It is however, important for
studying microcirculatory disturbances that may take
place in acute pancreatitis as a result of coagulopathy
and microvascular thrombosis [161]. The disadvan-
tages of this model are the requirements of large
experimental animals and time-consuming surgical
procedures. Although temporary arterial occlusion
shows a transient rise in circulating pancreatic en-
zymes, histological changes of acute pancreatitis are
minimal. Overall, the vascular-induced model has not
been particularly useful in investigating acute pan-
creatitis. There is evidence [174] that this model may
ultimately advance to chronic pancreatitis and may be
a useful tool to investigate the chronic form of this
disease.
Ischaemia/reperfusion model
Both clinical and experimental studies have shown
that ischaemic injury plays an important part in the
pathogenesis of acute pancreatitis. Ischaemic injury to
the pancreas is known to occur in various clinical
settings including cardiopulmonary bypass [175],
haemorrhagic shock [168] and transplantation of the
gland [176]. Studies have shown that there is correla-
tion between the impairment of microcirculation in
human pancreas with the degree of ischaemic injury
[177], and microvasculature presents the primary
target of reperfusion injury after ischaemia [178]. In
recent years, animal models have been developed to
investigate the ischaemia/reperfusion of the pancreas.
In 1995, Hoffman et al. [179] developed a model to
study the microcirculation of the pancreas in the rat
after complete (interruption of arterial blood supply
to the pancreas) and reversible ischaemia of the
pancreas using intravital fluorescence microscopy.
Blood supply for complete ischaemia of the pancreas
was impaired by isolating arteries from surrounding
tissue of gastroduodenal artery, left gastric artery,
splenic artery and caudal pancreaticoduodenal
artery. Complete but reversible ischaemia of the
pancreas was induced by occluding the four vessels
using microvascular clips. The clips were taken out
30 min, 1 h or 2 h after ischaemia to produce
reperfusion.
The characteristics noted following ischaemia/
reperfusion in the pancreas were similar to those
observed in the sodium taurocholate-induced acute
pancreatitis model [179]. The duration of ischaemia
and of reperfusion is responsible for the severity of
post-ischaemic inflammatory reaction. In addition,
there was a rise in the concentration of serum amylase
after 1 and 2 h of ischaemia [179]. Similar results
were observed by another group after 2 h of ischaemia
and 4 h of reperfusion [180]. Redha et al. [171]
reported even higher serum amylase concentrations
after ischaemia-induced acute pancreatitis. This may
occur because of the extended time (27 h) of
reperfusion. Under light and electron microscopy,
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the histological changes resembled those seen in the
caerulein-induced acute pancreatitis in the rat [181].
Ultrastructural changes after 2 h of ischaemia simu-
late acinar structural changes in pancreas grafts
following transplantation in human [182,183].
The current models used to induce ischaemia have
a number of restrictions involving reproducibility.
These limitations include incomplete ischaemia and
inability to quantitate the remaining blood supply to
the pancreas; irreversible ischaemia, making it not
suitable for reperfusion studies; and complete and
reversible ischaemia, limited to ex vivo models [179].
Furthermore, quantitative analysis of the post-ischae-
mic reperfusion failure at the microcirculation level is
also difficult to achieve. Various methods such as
methylene blue or India ink injection, radioactive
microspheres injection, light and electron microscopic
analysis of microangiographic architecture or laser
Doppler flowmetry cannot be used [184186]. The
advantage of the model developed by Hoffman et al.
[179] is that it enables complete and reversible
interruption of arterial blood supply to the pancreas.
By using the intravital fluorescence microscopy, the
parameters of microcirculation during the entire
reperfusion period can be assessed repetitively and
quantitatively [179].
Duct ligation model
Acute pancreatitis may be induced by ligating the
distal bile duct at the level of the duodenum [187].
This creates an early development of acute pancrea-
titis, obstructive jaundice and cholangitis in the rat.
The duct ligation model was developed in an attempt
to resemble the clinical situation of gallstones, motility
disorders of the sphincter, oedema and strictures at
the papilla, tumours of the papilla, and parasites
impacting the terminal biliopancreatic duct.
Surgical ligation of the pancreatic duct alone has
not been successful in inducing acute pancreatitis.
Most laboratory animals developed chronic lesions in
the pancreas characterized by atrophy and apoptosis
of acinar and ductal tissue, but not significant necrosis
or inflammation [188]. The ligation of the pancreatic
duct in rodents has become an established model for
chronic pancreatic atrophy and is often used for
studying pancreatic regeneration [189,190]. Ligation
of this common biliopancreatic duct in the rat,
however, causes a clinical syndrome resembling
the multiple organ failure observed in man. These
characteristics included pancreatic necrosis and
haemorrhage, white cell infiltration and multiple
microthrombi in the lung, stomach and kidney [191].
When Popper and Necheles [192] combined pan-
creatic duct ligation with the secretory stimulation,
secretin in dogs, mild acute oedematous pancreatitis
with fat necrosis was observed. Another study com-
bining duct ligation with both secretory stimulation
and minimal arterial blood produced a greater degree
of severity of acute pancreatitis [193]. Due to its
anatomical characteristics, the opossum has been
used to produce severe acute haemorrhagic necrotiz-
ing pancreatitis. This laboratory animal has a pan-
creatic main duct which drains into a long common
bile duct and both enter the duodenum at the papilla
[194,195]. Ligation of the pancreatic duct alone, bile
and pancreatic duct separately, or the common
biliopancreatic duct leads to severe acute pancreatitis
with mortality rates approaching 100% within 2 weeks
of induction [196,197]. The American opossum
model was frequently used to investigate the patho-
physiology of biliary acute pancreatitis.
This model of duct obstruction in the opossum is
useful because it closely simulates the mechanical
events that occur during or after gallstone passage
[198]. Using this model, acinar cell necrosis could be
identified as being the early point of injury in acute
necrotizing pancreatitis [194]. Studies have shown
that in duct-ligated rats, the predominant mechanism
of cell death is apoptosis [199]. In duct-ligated
opossums, necrosis is the primary mechanism; apop-
tosis is only present in the early phase of acute
pancreatitis [199]. Gukovskaya et al. [199] showed
that the extent of pancreatitic necrosis from duct-
ligated opossums corresponds with the elevated levels
of neutrophil infiltration. Neutrophils are thought to
produce mediators such as hydrogen peroxide and
oxygen that may be responsible for triggering necrosis
[199]. Pancreatic outflow obstruction seems to be the
critical pathophysiological event for the induction of
acute pancreatitis [195]. It appears that bile reflux is
not required for the pathogenesis of acute pancreatitis
in this model.
It has been suggested that induced sphincter of
Oddi (SO) dysfunction may be the cause of pancreatic
duct obstructions [200]. A recent study using
Australian brush tailed possums (Trichosurus vulpe-
cula), has shown for the first time, that induced SO
dysfunction when combined with stimulated pancrea-
tic secretion produces acute pancreatitis. Chen et al.
[201] demonstrated that transient obstruction of the
SO produced by carbachol administration led to
hyperamylasaemia and the histological changes corre-
lated with acute pancreatitis. These results were
similar to those induced in possums coupled with
pancreatic duct ligation and CCK-8/secretin admin-
istration [201], a method well established in inducing
hyperamylasaemia and acute pancreatitis in other
species. Both these models required the simultaneous
increase in pancreatic duct pressure with a combina-
tion of stimulated pancreatic exocrine to produce
hyperamylasaemia and acute pancreatitis [201].
This newly described possum model has been well
characterized. The model is useful for studying the
motility of the SO because it functions as a variable
resistor in modulating bile and pancreatic secretion
[202]. The arrangement of the pancreatic and bile
ducts come together and are controlled by an SO
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complex, resembling those of humans. In addition,
the responses to hormonal and drug stimuli are
comparable to humans [203]. This model is also
suitable for investigating the role of SO motility in
other forms of acute pancreatitis such as gallstone
pancreatitis, and pancreatitis secondary to alcohol,
scorpion envenomation, organophosphate poisoning
and octreotide treatment [200].
The duct ligation-induced model mainly correlates
with the clinical acute pancreatitis seen after Polya
gastrectomy. The advantage of the duct ligation model
is that it avoids artificial drug usage which may
produce unwanted systemic effects, as well as the
theory relating to clinical acute biliary acute pancrea-
titis with biliary pancreatic reflux [197]. However, the
complexity, technical difficulty, high cost, limited
reproducibility and the analogy to chronic pancreati-
tis, have made the duct ligation model infrequently
used for investigating acute pancreatitis. Chetty et al.
[129] modified this model in the rat so that gastro-
duodenostomy was not required. This model involves
a plastic tube to traverse the CDL to restore gastro-
intestinal continuity. In comparison to the conven-
tional model developed by Pfeffer et al. [124], the
modified model is cheaper and more readily available.
However, the co-existing duodenal wall necrosis and
pancreatic peritoneal sepsis often add complexity to
the model. This complicates interpretation of the
results [129].
Conclusion
In view of the methodological restrictions of the
established acute pancreatitis models for therapy
investigation, many attempts have been made to
develop, modify or combine available models to
more closely resemble human acute pancreatitis.
However, none of the existing experimental models
are completely satisfactory at the present time. There-
fore, comparison between the existing models is
complex and interpretations of results from various
studies are consequently difficult. The challenge is
exposing the animals to the same degree of severity
that triggers acute pancreatitis in man, such as
alcohol, bile duct obstruction, pancreatic ischaemia,
traumatic damage and various toxic substances.
Although the current experimental models are not
closely comparable to all the spectrum of human
acute pancreatitis, previously reported studies should
not be dismissed. Much of our current knowledge has
stemmed from existing experimental models; they
have contributed to our knowledge of mechanisms
involved in early cellular events, pathogenesis and
pathophysiology of acute pancreatitis. It has been
shown that certain models are better suited for
answering specific questions than others. Further
understanding and standardization of these models
may enable us to choose the most appropriate model
for studying a given aspect of acute pancreatitis or for
evaluating new treatment protocols. Thus, continued
research refining the present experimental design is
required in this area because the discovery of effective
treatments for acute pancreatitis will be extremely
beneficial.
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